Human Pharmacokinetics and Adverse Effects of Pulmonary and Intravenous THC-CBD Formulations
Background: Due to variable absorption and extensive first-pass metabolism, the bioavailability of oral delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) is low, and, therefore, alternative application forms are necessary. Methods: In an open-label, 2-period phase-1 study on 11 he...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Karger Publishers
2018-06-01
|
| coleção: | Medical Cannabis and Cannabinoids |
| Acesso em linha: | https://karger.com/article/doi/10.1159/000489034 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|